GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (FRA:XIN) » Definitions » Cyclically Adjusted Price-to-FCF

Shandong Xinhua Pharmaceutical Co (FRA:XIN) Cyclically Adjusted Price-to-FCF : 62.50 (As of Jun. 10, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

As of today (2024-06-10), Shandong Xinhua Pharmaceutical Co's current share price is €0.625. Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €0.01. Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is 62.50.

The historical rank and industry rank for Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:XIN' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 78.32   Med: 152.75   Max: 3860
Current: 78.43

During the past years, Shandong Xinhua Pharmaceutical Co's highest Cyclically Adjusted Price-to-FCF was 3860.00. The lowest was 78.32. And the median was 152.75.

FRA:XIN's Cyclically Adjusted Price-to-FCF is ranked worse than
78.26% of 322 companies
in the Drug Manufacturers industry
Industry Median: 31.22 vs FRA:XIN: 78.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shandong Xinhua Pharmaceutical Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €-0.003. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €0.01 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Shandong Xinhua Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 208.40 105.71

Shandong Xinhua Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 152.33 124.62 109.68 105.71 85.10

Competitive Comparison of Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=0.625/0.01
=62.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Shandong Xinhua Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.003/115.2271*115.2271
=-0.003

Current CPI (Mar. 2024) = 115.2271.

Shandong Xinhua Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.002 98.200 0.002
201409 0.003 98.900 0.003
201412 0.013 99.000 0.015
201503 -0.014 99.900 -0.016
201506 0.016 99.500 0.019
201509 0.019 100.500 0.022
201512 0.022 100.600 0.025
201603 0.000 102.200 0.000
201606 -0.001 101.400 -0.001
201609 0.024 102.400 0.027
201612 0.024 102.600 0.027
201703 -0.019 103.200 -0.021
201706 -0.011 103.100 -0.012
201709 0.024 104.100 0.027
201712 0.032 104.500 0.035
201803 -0.015 105.300 -0.016
201806 0.019 104.900 0.021
201809 -0.021 106.600 -0.023
201812 0.005 106.500 0.005
201903 -0.007 107.700 -0.007
201906 0.006 107.700 0.006
201909 -0.004 109.800 -0.004
201912 0.001 111.200 0.001
202003 0.011 112.300 0.011
202006 0.007 110.400 0.007
202009 0.023 111.700 0.024
202012 -0.012 111.500 -0.012
202103 0.008 112.662 0.008
202106 0.004 111.769 0.004
202109 -0.002 112.215 -0.002
202112 -0.008 113.108 -0.008
202203 -0.018 114.335 -0.018
202206 0.034 114.558 0.034
202209 -0.008 115.339 -0.008
202212 0.092 115.116 0.092
202303 -0.047 115.116 -0.047
202306 0.026 114.558 0.026
202309 -0.005 115.339 -0.005
202312 0.012 114.781 0.012
202403 -0.003 115.227 -0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shandong Xinhua Pharmaceutical Co  (FRA:XIN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Xinhua Pharmaceutical Co (FRA:XIN) Business Description

Traded in Other Exchanges
Address
No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo City, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.